Jessica Maria Exposito Escudero
Ayudante de investigación
Research group
The researcher Jesica María Expósito holds a degree in Medicine in 2012 from the University of Granada. She performs the specialty in Pediatrics and its specific areas in Hospital Universitario Nuestra Señora de Candelaria de Tenerife between 2014 and 2018. She has a Master's degree in Pediatric Emergency by the Catholic University of Valencia and is an expert in Child and Adolescent Psychiatry by the University of Barcelona. She is currently studying the Master's Degree in Neuropediatrics at the University of Barcelona.
In 2018, she joined the research team of the Neuromuscular Pathology Unit of the Hospital Sant Joan de Déu.
Professional network profiles
Last Publications
- Nascimento-Osorio A, Ortez-Gonzalez CI, Exposito-Escudero JM, Carrera-García L, Cerezo, S, Lotz, S, Zschaeck-Luzardo I, Alejandro Luján Feliu-Pacual, Gatnau, C, Estévez-Arias B, Tizzano E and Natera-de Benito D Neuromuscular diseases in pediatrics with specific treatments MEDICINA-BUENOS AIRES . 85: 34-40.
- Cerezo, S, Exposito-Escudero JM, Carrera-García L, Natera-de Benito D, Nascimento-Osorio A and Ortez-Gonzalez CI Immune-mediated polyneuropathies MEDICINA-BUENOS AIRES . 85: 41-46.
- Armijo JA, Nascimento-Osorio A, Exposito-Escudero JM, Carrera-García L, Natera-de Benito D and Ortez-Gonzalez CI Natural history of patients with nonsense mutation Duchenne muscular dystrophy treated with ataluren in Spain. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology . 44(3): 96-103.
Projects
- Project name:
- Realización de un ensayo observacional maestro orientado a las enfermedades raras para descifrar la complejidad y optimizar la preparación del ensayo; red PROMOTE
- Leader
- Daniel Natera de Benito
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- AC23_2/00026
- Starting - finishing date:
- 2024 - 2026
- Project name:
- Cerrando la brecha terapeutica para Distrofias Musculares Congenitas. Estrategias para mejorar la eficacia, liberacion y seguridad de terapias basadas en CRISPR/Cas9 y oligonucleotidos
- Leader
- Cecilia Jiménez Mallebrera
- Funding entities:
- Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD, Jiménez Mallebrera, Cecilia
- Code
- PI22/01382
- Starting - finishing date:
- 2023 - 2026
- Project name:
- Identificación de predictores de arritmias cardiacas y muerte súbita en pacientes pediatricos afectos de enfermedades neuromusculares
- Leader
- Georgia Sarquella Brugada
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI21/00094
- Starting - finishing date:
- 2022 - 2026
News
-
The first clinical trial of a gene therapy for Duchenne in children under 4 years old is initiated.
A research team from the Institut de Recerca Sant Joan de Déu · SJD Barcelona Children's Hospital is participating in an international clinical trial of a gene therapy for Duchenne muscular dystrophy in children under 4 years old.
